WO2004071389A3 - Non-steroidal infalmmation inhibitors - Google Patents

Non-steroidal infalmmation inhibitors Download PDF

Info

Publication number
WO2004071389A3
WO2004071389A3 PCT/EP2004/001507 EP2004001507W WO2004071389A3 WO 2004071389 A3 WO2004071389 A3 WO 2004071389A3 EP 2004001507 W EP2004001507 W EP 2004001507W WO 2004071389 A3 WO2004071389 A3 WO 2004071389A3
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
represents hydrogen
nr8cor9
conr8r9
coor7
Prior art date
Application number
PCT/EP2004/001507
Other languages
French (fr)
Other versions
WO2004071389A2 (en
Inventor
Michael David Barker
Derek Anthony Demaine
David House
Graham George Adam Inglis
Michael John Johnston
Haydn Terence Jones
Simon John Fawcett Macdonald
Iain Mcfarlane Mclay
Stephen Shanahan
Philip Alan Skone
Maria Victoria Vinader
Original Assignee
Glaxo Group Ltd
Michael David Barker
Derek Anthony Demaine
David House
Graham George Adam Inglis
Michael John Johnston
Haydn Terence Jones
Simon John Fawcett Macdonald
Iain Mcfarlane Mclay
Stephen Shanahan
Philip Alan Skone
Maria Victoria Vinader
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0303523A external-priority patent/GB0303523D0/en
Priority claimed from GB0305721A external-priority patent/GB0305721D0/en
Priority claimed from GB0305717A external-priority patent/GB0305717D0/en
Priority claimed from GB0316865A external-priority patent/GB0316865D0/en
Application filed by Glaxo Group Ltd, Michael David Barker, Derek Anthony Demaine, David House, Graham George Adam Inglis, Michael John Johnston, Haydn Terence Jones, Simon John Fawcett Macdonald, Iain Mcfarlane Mclay, Stephen Shanahan, Philip Alan Skone, Maria Victoria Vinader filed Critical Glaxo Group Ltd
Publication of WO2004071389A2 publication Critical patent/WO2004071389A2/en
Publication of WO2004071389A3 publication Critical patent/WO2004071389A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A compound of formula (I) wherein: n represents an integer 0, 1 or 2; X represents, O, S, NR6a, or CHR6b; R1 represents hydrogen, halogen such as F, Cl or Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7 or CONR8R9; R2 represents hydrogen, halogen such as F, Cl, Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7 or CONR8R9; R3 represents hydrogen, halogen such as F, Cl, Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7, CONR8R9; R4 represents hydrogen, halogen such as F, Cl, Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7 or CONR8R9; R5 represents H, C1-6 alkyl, or C1-6 alkenyl; R6a represents hydrogen, C1-6 alkyl, CO2C1-3 alkyl, COC1-3 alkyl or SO2C1-3 alkyl; R6b represents hydrogen, or C1-6 alkyl; R7 represents hydrogen, C1-6 alkyl, C1-3 alkyleneSiC1-3 alkyl such as -CH2CH2Si(CH3)3; R8 and R9 independently represent hydrogen or C1-6 alkyl; including pharmaceutically acceptable esters, amides and carbamates thereof, salts thereof, solvates thereof, and solvates of such pharmaceutically acceptable esters, amides, carbamates and salts.
PCT/EP2004/001507 2003-02-15 2004-02-13 Non-steroidal infalmmation inhibitors WO2004071389A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB0303523.5 2003-02-15
GB0303523A GB0303523D0 (en) 2003-02-15 2003-02-15 Compounds
GB0305721A GB0305721D0 (en) 2003-03-13 2003-03-13 Compounds
GB0305717A GB0305717D0 (en) 2003-03-13 2003-03-13 Compounds
GB0305721.3 2003-03-13
GB0305717.1 2003-03-13
GB0316865A GB0316865D0 (en) 2003-07-18 2003-07-18 Compounds
GB0316865.5 2003-07-18

Publications (2)

Publication Number Publication Date
WO2004071389A2 WO2004071389A2 (en) 2004-08-26
WO2004071389A3 true WO2004071389A3 (en) 2004-12-02

Family

ID=32872852

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/001507 WO2004071389A2 (en) 2003-02-15 2004-02-13 Non-steroidal infalmmation inhibitors

Country Status (1)

Country Link
WO (1) WO2004071389A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04009329A (en) 2002-03-26 2005-01-25 Boehringer Ingelheim Pharma Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof.
UY28526A1 (en) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma GLUCOCORTICOID MIMETICS, METHODS OF PREPARATION PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
WO2006000398A1 (en) * 2004-06-28 2006-01-05 Glaxo Group Limited 2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
GB0418045D0 (en) 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
JP2008525525A (en) 2004-12-27 2008-07-17 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド Glucocorticoid mimetic, its production, pharmaceutical composition and use
GB0513297D0 (en) * 2005-06-29 2005-08-03 Glaxo Group Ltd Novel compounds
GB0611587D0 (en) * 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
WO2008000777A2 (en) * 2006-06-29 2008-01-03 Glaxo Group Limited Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use
CN101547909A (en) 2006-12-06 2009-09-30 贝林格尔.英格海姆国际有限公司 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US20100035926A1 (en) * 2006-12-20 2010-02-11 Ian Baxter Campbell Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
AU2009256289A1 (en) 2008-06-06 2009-12-10 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US9382245B2 (en) 2013-10-11 2016-07-05 Yale University Compounds and methods for treating HIV infections
TW202304462A (en) * 2021-03-23 2023-02-01 美商美國禮來大藥廠 Glucocorticoid receptor agonists

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032584A2 (en) * 1998-11-27 2000-06-08 Schering Aktiengesellschaft Nonsteroidal antiinflammatories
WO2002010143A1 (en) * 2000-07-28 2002-02-07 Schering Aktiengesellschaft Non-steroidal inflammation inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032584A2 (en) * 1998-11-27 2000-06-08 Schering Aktiengesellschaft Nonsteroidal antiinflammatories
WO2002010143A1 (en) * 2000-07-28 2002-02-07 Schering Aktiengesellschaft Non-steroidal inflammation inhibitors

Also Published As

Publication number Publication date
WO2004071389A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
WO2004071389A3 (en) Non-steroidal infalmmation inhibitors
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
EP1760073A4 (en) Sulfonamide compound
MEP22008A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
NO20062031L (en) Derivatives of N- [phenyl (alkylpeptidn-2-yl) methyl] benzamide, process for its preparation and use in therapeutic media
RS54607B1 (en) 5-substituted quinazolinone derivatives as anti-cancer agents
RS53839B1 (en) Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
RS52099B (en) Substituted benzimidazoles as kinase inhibitors
HRP20020175B1 (en) N-heterocyclikc derivatives as nos inhibitors
WO2004013101A3 (en) N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
EA200700441A1 (en) NEW HETEROCYCLIC INHIBITORS NF-κB
EA200501730A1 (en) DERIVATIVES N-PYRROLIDIN-3-IL-AMIDA AS AN INHIBITORS OF REVERSE CAPTURE OF SEROTONIN AND NORADRENALINE
DK1485377T3 (en) Pyranones are suitable as ATM inhibitors
RS20100169A (en) Intermediates for the preparation of dioxan-2-alkyl carbamates
PE20011115A1 (en) TRI-ARIL-SUBSTITUTED ETHANS, PDE4 INHIBITORS
RS53180B (en) Novel seh inhibitors and their use
NO20061832L (en) Carbamide derivatives of amide type
EP1798227A4 (en) Serotonin 5-ht3 receptor agonist
EA200600607A1 (en) IMIDAZOPIRIDIN DERIVATIVES AS AN INDUCED NO SYNTHASE INHIBITORS
NO20071319L (en) Process for the preparation of isothiazole derivatives.
HK1096548A1 (en) Imidazopyridine-derivatives as inductible no-synthase inhibitors
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
DK1202954T3 (en) Novel aminobenzophenones
ATE374750T1 (en) SEROTONIN RUPUP INHIBITORS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase